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Yeast prions: Inheritance by seeded protein polymerization?
Peter T. Lansbury, Jr
Recent studies suggest that certain proteins may have
properties that used to be thought specific to nucleic
acids — they can transmit heritable traits in yeast and
neurodegenerative diseases in mammals by a common
mechanism, seeded protein polymerization.
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The discovery that RNA enzymes — ribozymes — can
fulfill a function previously thought to be the exclusive
province of proteins has had far-reaching implications. It
has recently become apparent that certain proteins may
have the ability to transmit information and to self-repli-
cate, functions normally associated with nucleic acids. The
first self-replicating entity proposed to be ‘protein-only’
was the scrapie infectious agent [1–4]. As the composition
of this agent has not been definitively resolved, the possi-
bility exists that it may be a very small, abnormally stable
virus [5]. However, the ‘protein-only’ scenario, which
holds that the agent is a protein with virus-like biological
properties [2–4] — commonly referred to as a prion — is
also attractive, especially in light of recent work in an
apparently unrelated area, yeast genetics. Two non-
Mendelian heritable traits in yeast, long thought to be
transmitted by an unusual nucleic acid element, now
appear to be transmitted by proteins, without the need for
nucleic acid [6–9]. What makes the analogy between yeast
inheritance and scrapie transmission more compelling is
that the two ‘protein-only’ phenomena may share a
common mechanism — nucleation-dependent, or seeded,
polymerization [10–12].
Two inherited traits in yeast, called [PSI+] and [URE3],
have been known for almost thirty years to be inherited in a
non-Mendelian manner [6]. For example, a cross between
[PSI–] and [PSI+] yeast produces progeny all of which are
[PSI+] (Figure 1). Furthermore, the [PSI+] and [URE3]
phenotypes are metastable; they disappear spontaneously
and are ‘cured’ by treatment with the protein denaturant
guanidinium hydrochloride. The conversion of [PSI–] to
[PSI+] can be induced by overexpression of the SUP35
gene, and the [URE3] trait is induced by mutation of the
URE2 gene. The protein products of these two genes,
Sup35 and Ure2, have essential functions; the former is a
subunit of the translation terminator and the latter is
involved in nitrogen metabolism. The sequences of the two
proteins are not similar, but both contain amino-terminal
domains that have unusual amino acid compositions and are
not essential for their normal function. In either case, dele-
tion of the amino-terminal domain prevents the inheritance
of the trait, while its overexpression can induce the trait.
These and other factors led Wickner [13] to propose that
these two proteins are analogous to the scrapie
transmissible agent, in that all three may be transmitted
by an abnormal form of a normal cellular protein (hence
the designation ‘yeast prions’). This analogy equates the
‘dominant’ traits [PSI+] and [URE3] with the scrapie
disease state, and holds that the conversion of a normal
protein to an abnormal form induces the abnormal state.
Before describing the recent evidence suggesting that this
analogy can be extended to the mechanistic level, I shall
briefly review the history of ideas regarding scrapie
transmission, so that Wickner’s inspiration can be more
readily appreciated.
The abnormal physical properties of the scrapie infectious
agent led several individuals to propose, in the early-to-
mid sixties, that the agent may contain only protein and
no nucleic acid genome [2,3]. In 1967, Griffith [1] sug-
gested several mechanisms by which a ‘protein-only’
scrapie infectious agent could replicate; one of these
involved seeded polymerization. Prusiner [14] and
coworkers subsequently identified the primary protein
constituent of the agent, and named it the prion protein
(PrP). As no covalent differences have been identified
between the normal cellular form of the prion protein
(PrPC) and the disease-associated form (PrPSc), it was pro-
posed that the two forms are differentiated by their con-
formation [1,15]. It is not clear, however, whether these
differences involve secondary structure (helices, β-turns
and so on), tertiary structure (overall fold), quarternary
structure (oligomerization state) or a combination of these.
Griffith [1] proposed, as one among several possibilities,
that PrPSc is an ordered polymeric form of PrP, and that
monomeric PrPC is slow to convert into PrPSc because of
the entropic barrier to nucleation of polymerization.
According to this scenario, exogenous, or infective, PrPSc
can seed the polymerization of PrPC. We were drawn to
this mechanistic possibility because of analogy with the
process of amyloid formation: PrPSc often exhibits proper-
ties of amyloid, and peptide fragments of PrP polymerize
by a nucleation-dependent mechanism [11,16]. However,
although many amyloidogenic proteins, such as the
amyloid β protein of Alzheimer’s disease [17], polymerize
readily in vitro, PrP does not.
Rapid amyloid formation by amyloid β protein can be
induced by seeding with preformed fibrils, and guided by
this observation we were able to convert PrPC to a form
that is biochemically indistinguishable from PrPSc, using
PrPSc from infected brain as a seed [18]. This cell-free
reaction exhibits all of the properties of scrapie transmis-
sion, including species barriers and strain-specificity
[19–21]. The PrPSc-derived in vitro seed is denser and has
a larger hydrodynamic radius than denatured PrP, as
would be expected of an oligomeric seed [22], and is indis-
tinguishable from scrapie infectivity — the in vivo seed?
— in its sensitivity to denaturation [23]. So it seems possi-
ble that the in vitro conversion reaction mimics in vivo
infection, and that both are seeded by an ordered PrP
oligomer. The critical test of the ‘protein-only’ hypothesis
would be to demonstrate that new infectivity is created
from added PrPC in the cell-free conversion reaction.
In the case of the yeast prion, it has been much easier to
bridge the in vitro studies and the biological phenomenon.
The [PSI+] trait has clearly been shown to be linked to
the aggregation of Sup35 in the yeast cytoplasm [24]
(scrapie is linked to the aggregation of PrP into a protease-
resistant form [2,3]). Three recent papers [7–9] have
shown that Sup35 and its amino-terminal domain form
amyloid fibrils in vitro by a nucleated polymerization
mechanism. Lindquist and coworkers [7] showed that
purified Sup35 and its isolated ‘prion’ domain form
amyloid fibrils in vitro by a nucleated polymerization
mechanism. This process could be seeded by preformed
fibrils or by cytoplasm from [PSI+] cells. Wuthrich and
coworkers [8] reported similar studies of the Sup35 prion
domain. And Ter-Avanesyan and coworkers [9] demon-
strated that the cytoplasmic factor responsible for seeding
the in vitro conversion of the normal, highly soluble form
of the Sup35 protein to a denser, higher molecular weight
form is a protein aggregate, consistent with its being a
polymerization seed (the seed for in vitro PrPC-to-PrPSc
conversion has similar properties [22]). 
This seeded polymerization mechanism explains how
treatment with a chemical denaturant can disaggregate the
fibrillar form of Sup35 and restore the [PSI–] phenotype
(Figure 1). Ter-Avanesyan and coworkers [9] demon-
strated that the cytoplasm-derived [PSI+] form could
induce the conversion of 400-fold excess of the normal,
monomeric form of Sup35 (a much more efficient version
of the cell-free conversion of PrPC to PrPSc [18]). What
remains to be done is to induce the [PSI+] phenotype by
direct injection of the Sup35 amyloid, formed in vitro, into
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Figure 1
Analogies between [PSI+] inheritance in
yeast and scrapie transmission in
experimental animals. The in vitro mechanism
is overlaid on the biological phenomena, but
this link has not been clearly made in either
case. In both cases, the key proteins are
normally monomeric: Sup35 is a translational
terminator; the function of PrPC is unknown.
Spontaneous conversion of [PSI–] yeast to
[PSI+] — presumably by polymerization of
Sup35 as shown — is known to occur,
especially when SUP35 is overexpressed;
reversion to [PSI–] can occur, but is rare. In
the case of scrapie, the spontaneous
conversion — PrPC-to-PrPSc — is very rare,
and there is no information about
spontaneous ‘cures’. [PSI+] yeast, when
mated with [PSI–] yeast, produce progeny all
of which are [PSI+]; this is termed
inheritance, but is actually infection by
cytoplasmic transfer. Similarly, brain tissue
containing PrPSc from scrapie animals will
infect normal animals; infectivity replicates in
these animals, suggesting that host PrPC is
converted to PrPSc. Infectious scrapie agent
can be deactivated by treatment with the
denaturant guanidine. In addition, scrapie-
infected cell cultures can be ‘cured’ with
guanidine. Similarly, the [PSI+] phenotype
can be ‘cured’ by growing the organisms in
guanidine. All of these observations are
consistent with the transmitting agent being
an ordered oligomeric seed for protein
polymerization. Proteins Sup35 and PrP have
been colored according to the organism of
origin to show that the normal protein is
’converted’ to the abnormal form.
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the cytoplasm of [PSI–] yeast, to establish clearly the link
between the seeded polymerization mechanism and
inheritance of the [PSI+] trait. 
There is much work to be done to prove that protein
polymerization seeds are involved in scrapie transmission
and yeast inheritance — both phenomena that would
typically be expected to require nucleic acid. The exis-
tence of a working mechanistic hypothesis, however,
allows the design of diagnostic experiments, many of
which are in progress. As a last comment, it is possible that
there are additional examples of seeded protein polymer-
ization that have gone unrecognized, not only in disease
pathogenesis [10] but also in ‘normal’ biology [6].
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